Biomarkers of body iron stores and risk of developing type 2 diabetes

Aim:  Iron may contribute to the pathogenesis of type 2 diabetes mellitus (DM) by inducing oxidative stress and interfering with insulin secretion. Elevated ferritin levels are associated with increased DM risk among healthy individuals. However, it is yet unknown if ferritin predicts DM incidence among high‐risk individuals with impaired glucose tolerance (IGT). Furthermore, the association between soluble transferrin receptors (sTfR), a novel marker of iron status, and DM risk has not yet been prospectively investigated in these individuals. We conducted this study to evaluate the association between baseline levels of ferritin and sTfR and the risk of developing DM among overweight and obese individuals at high risk of DM.

[1]  A. Clague,et al.  Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron‐deficient erythropoiesis in a heterogeneous group of patients , 2007, Pathology.

[2]  J. Pankow,et al.  A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. , 2007, American journal of epidemiology.

[3]  M. Sandhu,et al.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study , 2007, Diabetologia.

[4]  K. Sung,et al.  Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein. , 2007, Archives of medical research.

[5]  J. Manson,et al.  Prospective Study of , 2007 .

[6]  B. Balkau,et al.  Ferritin and Transferrin Are Both Predictive of the Onset of Hyperglycemia in Men and Women Over 3 Years , 2006, Diabetes Care.

[7]  A. Green,et al.  Transferrin and iron induce insulin resistance of glucose transport in adipocytes. , 2006, Metabolism: clinical and experimental.

[8]  D. Reboussin,et al.  Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. , 2005, Diabetes care.

[9]  S. Puntarulo.  Iron, oxidative stress and human health. , 2005, Molecular aspects of medicine.

[10]  J. L. San Millán,et al.  Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. , 2005, Diabetes care.

[11]  R. Simó,et al.  Soluble transferrin receptors and ferritin in Type 2 diabetic patients , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[12]  E. Guallar,et al.  Serum ferritin and risk of the metabolic syndrome in U.S. adults. , 2004, Diabetes care.

[13]  P. Alpert.  New and Emerging Theories of Cardiovascular Disease: Infection and Elevated Iron , 2004, Biological research for nursing.

[14]  R. MacIsaac,et al.  Elevated iron indices in patients with diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[15]  O'Reilly Ds.  The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. , 2004 .

[16]  B. Wells,et al.  Association of ferritin and lipids with C-reactive protein. , 2004, The American journal of cardiology.

[17]  J. Manson,et al.  Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. , 2004, JAMA.

[18]  H. Tian,et al.  Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolerant first-degree relatives in familial type 2 diabetic pedigrees. , 2004, Diabetes care.

[19]  W. Stremmel,et al.  Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? , 1984, Diabetologia.

[20]  L. Tilbrook.  Cross talk between iron metabolism and diabetes. , 2004, Annals of clinical biochemistry.

[21]  Xi Huang.  Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. , 2003, Mutation research.

[22]  S. Grambow,et al.  Potential role of increased iron stores in diabetes. , 2003, The American journal of the medical sciences.

[23]  Lih-Yuan Lin,et al.  A relationship between serum ferritin and the insulin resistance syndrome is present in non‐diabetic women but not in non‐diabetic men , 2003, Clinical endocrinology.

[24]  J. George,et al.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis , 2003, Current gastroenterology reports.

[25]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[26]  A. Stein,et al.  Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. , 2002, The American journal of clinical nutrition.

[27]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. , 2002, Diabetes care.

[28]  R. Poulton,et al.  Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. , 2002, Atherosclerosis.

[29]  J. Fernández-Real,et al.  Cross-talk between iron metabolism and diabetes. , 2002, Diabetes.

[30]  G. Mancia,et al.  Increased serum ferritin is common in men with essential hypertension , 2002, Journal of hypertension.

[31]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. , 2002, Diabetes.

[32]  M. Stampfer,et al.  Body iron stores and coronary heart disease. , 2002, Clinical chemistry.

[33]  R. Nelson.  Iron and colorectal cancer risk: human studies. , 2009, Nutrition reviews.

[34]  Babatyi I. Malope,et al.  The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status , 2001, British journal of haematology.

[35]  R. Stoohs,et al.  Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians , 2001, British Journal of Nutrition.

[36]  P. Brissot,et al.  Venesection therapy of insulin resistance-associated hepatic iron overload. , 2001, Journal of hepatology.

[37]  R. Gillum.  Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—the Third National Health and Nutrition Examination Survey , 2001, International Journal of Obesity.

[38]  M. Lishner,et al.  PLASMA FERRITIN AND TYPE 2 DIABETES MELLITUS: A CRITICAL REVIEW , 2001, Endocrine research.

[39]  E. Ferrannini.  Insulin resistance, iron, and the liver , 2000, The Lancet.

[40]  J. Boeynaems,et al.  Measurement of soluble transferrin receptor by immunoturbidimetry and immunonephelometry. , 2000, Clinical biochemistry.

[41]  C. Champagne,et al.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. , 2000, Diabetes care.

[42]  E. Ford,et al.  Diabetes and serum ferritin concentration among U.S. adults. , 1999, Diabetes care.

[43]  C. Lok,et al.  The transferrin receptor: role in health and disease. , 1999, The international journal of biochemistry & cell biology.

[44]  W. Ricart,et al.  C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes. , 1999, Diabetes care.

[45]  Melvin Prince,et al.  The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. , 1999, Diabetes care.

[46]  K. Kowdley,et al.  Diagnosis of Hemochromatosis , 1998, Annals of Internal Medicine.

[47]  M. Pippard,et al.  Iron Homeostasis and the Assessment of Iron Status , 1998, Annals of clinical biochemistry.

[48]  H. Lakka,et al.  Relation between iron stores and non-insulin dependent diabetes in men: case-control study , 1998, BMJ.

[49]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[50]  J. Fernández-Real,et al.  Serum Ferritin as a Component of the Insulin Resistance Syndrome , 1998, Diabetes Care.

[51]  K. Hughes,et al.  Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. , 1998, Atherosclerosis.

[52]  C. Beaumont,et al.  Function and regulation of transferrin and ferritin. , 1998, Seminars in hematology.

[53]  M. Scott,et al.  Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. , 1998, Clinical chemistry.

[54]  C. Caspersen,et al.  Introduction to a Collection of Physical Activity Questionnaires , 1997 .

[55]  T. Lakka,et al.  Body Iron Stores Are Associated With Serum Insulin and Blood Glucose Concentrations: Population study in 1,013 eastern Finnish men , 1997, Diabetes Care.

[56]  J. Keul,et al.  Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. , 1997, Atherosclerosis.

[57]  K. Punnonen,et al.  Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. , 1997, Blood.

[58]  W. Willett,et al.  Are body iron stores related to the risk of coronary heart disease? , 1994, The New England journal of medicine.

[59]  F. Torti,et al.  Iron and ferritin in inflammation and cancer. , 1994, Advances in inorganic biochemistry.

[60]  J. Sullivan.  Iron and coronary heart disease. Iron makes myocardium vulnerable to ischemia. , 1993, BMJ.

[61]  D. Simonson,et al.  Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. , 1993, Journal of diabetes and its complications.

[62]  S. Wolff.  Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. , 1993, British medical bulletin.

[63]  S. Dinneen,et al.  Serum ferritin in newly diagnosed and poorly controlled diabetes mellitus , 1992, Irish journal of medical science.

[64]  M. Czech,et al.  Insulin injection increases the levels of serum receptors for transferrin and insulin-like growth factor-II/mannose-6-phosphate in intact rats. , 1990, Endocrinology.

[65]  R. Davis,et al.  Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. , 1986, The Journal of biological chemistry.

[66]  C. McLaren,et al.  Binding of Serum Ferritin to Concanavalin A: Patients with Hornozygous β Thalassaemia and Transfusional Iron Overload , 1980, British journal of haematology.

[67]  R. L. Prentice,et al.  Retrospective studies and failure time models , 1978 .

[68]  M. Simon,et al.  [Diabetes and hemochromatosis. I. Diabetes in idiopathic hemochromatosis. Apropos of 130 personal cases of hemochromatosis]. , 1973, La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris.

[69]  M. Simon,et al.  [Diabetes and hemochromatosis. II. Diabetes of idiopathic hemochromatosis and common diabetes. Apropos of 130 personal cases of hemochromatosis]. , 1973, La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris.